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Abstract
Background: Majority of Nepalese women live in remote rural areas, where health services are not easily
accessible. We determined the validity of Menopause Rating Scale (MRS) as a screening tool for identification of
women with severe menopausal symptoms and cut-off MRS score for referral.
Methods: A cross-sectional survey was carried out between February and August, 2008. Trained health workers
administered MRS and a questionnaire to 729 women (40 to 65 years) attending health screening camps in Kaski
district of Western Development Region of Nepal. Information about demographics, menopausal status, and use of
hormone replacement therapy (HRT), chronic disease, self-perceived general health and reproductive history was
also collected. Menopausal status was classified according to the Staging of Reproductive Ageing Workshop
(STRAW). We calculated rates of menopausal symptoms, sensitivity, and specificity and likelihood ratios of MRS
scores for referral to a gynaecologist. We also carried out multivariate analyses to identify the predictors for referral
to a gynaecologist for severe symptoms.
Results: A total 729 women were interviewed. Mean age at menopause was 49.9 years (SD 5.6). Most frequently
reported symptoms were, sleeping problems (574, 78.7%), physical and mental exhaustion (73.5%), hot flushes (508,
69.7%), joint and muscular discomfort (500, 68.6%) and dryness of vagina (449, 61.6%). Postmenopausal women
(247, 33.9%) and perimenopausal (215, 29.5%) women together experienced significantly higher prevalence of all
symptoms than the premenopausal (267, 36.6%) women. MRS score of ≥16 had highest ratio for (sensitivity +
specificity)/2. Women who reported urogenital symptoms [OR 5.29, 95% CI 2.59, 10.78], and self perceived general
health as poor [OR 1.29, 95% CI 1.11, 1.53] were more likely to be referred to a gynaecologist for severe
menopausal symptoms. While women reporting somatic [OR 0.72, 95% CI 0.63, 0.82] and psychological [OR 0.86,
95% CI 0.74, 0.99] symptoms were less likely to be referred.
Conclusion: MRS may be used as a screening tool at a cut-off score of ≥16 with least misclassification rate.
However, its utility may be limited by woman’s general health status and occurrence of urogenital symptoms.
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Menopause is a condition caused by the depletion of ovar-
ian function followed by cessation of menstruation in
women. Modern medicine has significantly prolonged the
life span of humans and most women spend one-third to
half of their lifetime in post- menopause [1]. Information
about menopausal experiences among different racial and
ethnic groups is important for healthcare personnel to
provide appropriate and specific interventions [2,3]. It has
been shown that menopausal symptoms vary according to
racial groups. For instance, studies have reported that
somatic and psychological symptoms are less frequent
among Asian women as compared to Caucasian women
[4-7]. Further, menopausal symptoms may also vary
according to menopausal status. Vasomotor, sexual and
psychological symptoms a r em o r ef r e q u e n ta m o n g
perimenopausal and postmenopausal women [8-10].
During menopause, women often experience some
symptoms which may affect their daily activities. In recent
years, studies have shown that menopausal symptoms may
affect health-related quality of life [11,12]. Menopause
Rating Scale (MRS) which is a health related quality of life
(HRQOL) scale was developed in the early 1990’s in Ger-
many [13,14]. Since then, MRS has been well accepted
internationally and has been translated into several
languages [15] taking international methodological recom-
mendations into consideration [16]. Use of MRS in Turk-
ish language has been validated [17] and also used as an
instrument to assess the frequency menopausal symptoms
among middle aged women in eastern Malaysia, Northern
India, Sri Lanka and Ecuador [8,10,18,19]. MRS has a
potential of being used as a screening tool to identify
those women in need of referral to higher level for severe
menopausal symptoms. Such use of MRS would be more
appropriate in remote and rural areas of Nepal. In rural
Nepal, health care facilities are less accessible to women
due to geographic, cultural and social barriers. In such set-
tings, the community health workers may administer MRS
to identify the women who are in need of secondary or
tertiary level care for severe menopausal symptoms.
Therefore it is important to test the validity of MRS as a
screening tool. We aimed to determine the frequency of
menopausal symptoms among rural Nepalese women; to
test the validity of MRS as a screening tool for identifica-
tion of severe menopausal symptoms; and to determine
the cut-off MRS score for referral to specialist consulta-
t i o n .T ot h eb e s to fo u rk n o w l e d g e ,s u c hs t u d yh a sn o t
been carried out in Nepal.
Methods
Study design
A cross-sectional, interviewer administrated question-
naire survey
Setting and participants
Kaski district is one of the 14 districts in Western
Development Region (WDR) of Nepal. In WDR of
Nepal most districts are rural and remote, where access
to healthcare services and information is very limited.
Kaski district has a land area of 2000 squares kilometres
and a population of 380, 000. Kaski district has 43 vil-
lages and Pokhara sub metropolitan city which has a
population of 156, 000 according to the 2001 census
[20]. In Nepal, healthcare is offered mainly through Pri-
mary Health Centres (PHCs), operated by the Ministry
of Health and manned by General Practitioners (GPs),
Auxiliary Nurse Midwives (ANMs), Auxiliary Health
Workers (AHWs) and health assistants (HAs). Bedabari
PHC is adjacent to Pokhara city and Batulechaur Health
Post (HP) is a under Bedabari PHC. Each PHC serves a
population of 100,000 and HP serves 30,000 population.
This study was carried out at afore-mentioned health
facilities and the participants were women aged between
40 and 65 years who voluntarily attended the health
screening camps.
Instrument
The questionnaire was divided into four sections
(additional files 1 and 2). The first section included the
following information about women’s socio-demographic
characteristics: age, marital status, living situation, educa-
tion and occupation. The second section included ques-
tions about menopausal status at the time of the study,
menstrual history and symptoms of dysmenorrhoea
experienced in the past. Menopausal status was defined
according to STRAW (Stages of Reproductive Aging
Workshop) classification. STRAW categorises and
defines menopausal women as follows: Premenopause:
minor changes in cycle length particularly decreasing
length of the cycle. Late perimenopause: had menstrua-
tion during the past 2-12 months but not during the past
two months. Early perimenopause: had increasing irregu-
larity of menses without skipping periods (7 days differ-
ence from the beginning of a given cycle to the next)
experienced after the previously regular cycle. Postmeno-
pausal: no menstrual bleeding during the past 12 months
[21,22]. Early and late perimenopause were combined
into perimenopausal stage for our analysis. The third
section included questions about presence of any chronic
diseases (diabetes, hypertension, bronchial asthma, car-
diac disease etc), use of HRT and the women were asked
to rate self-perceived general health and wellbeing as
good or poor. In the last section women were asked if
they had experienced any symptoms based on the MRS,
since the age of 40 years. We used the English version of
MRS without modification. The original German version
of MRS has been translated into English and other
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questionnaire and is widely tested and accepted interna-
tionally [13-16]. During the interview women were asked
to report symptoms and also asked to rate the severity of
symptoms as ‘mild’, ‘moderate’, ‘severe’ or ‘very severe’
[14]. If any of the symptoms listed in MRS were not
reported by women then it was marked as ‘none’.M R S
score was generated by summing the score given for each
of the 11 symptoms. Scoring for each symptom was given
as follows: none = 0, mild = 1, moderate = 2, severe = 3,
very severe = 4.
Ethics and informed consent
This survey was approved by the research ethics com-
mittee of Manipal College of Medical Sciences, Pokhara,
Nepal. The women were provided with information
about nature of interview to be conducted and participa-
tion was voluntary. They were assured about confidenti-
ality of the information to be provided. Informed
consent was taken from each eligible woman before the
questionnaire interview was administered.
Data collection
During February 2008 to August 2008, health screening
camps were held in Bedabari PHC and Batulechaur HP.
We included all women aged between 40 to 65 years.
The women were checked for the exclusion criteria
during registration process at the reception desk of the
camps. The exclusion criteria were the following:
pregnant and lactating mothers, women with history of
cancer in remission or under treatment currently; history
of alcohol or drug abuse and any mental disability or
undergoing treatment for psychiatric disorders. Women
with premature ovarian failure or known genital malfor-
mations were also excluded. If the woman was found
eligible, she was invited to participate in the study. To
each eligible woman explanation about purpose of the
interview was given and informed consent was taken.
A face-to-face interview was conducted by paramedical
health personnel who were trained about the question-
naire and the English version of MRS. All the interviews
took place in the local language, Nepalese.
Statistical Analysis
Data was coded and entered into Microsoft Excel. The
data was converted into SPSS and STATA packages for
analysis. We used descriptive statistics to summarise the
demographic variables. Frequency of occurrence and
severity (as severe and very severe) of symptoms were
calculated as percentages. We compared mean ages,
MRS scores and severity of symptoms between premeno-
pausal, perimenopausal and postmenopausal status of the
women according to STRAW classification. Total MRS
Score, and sub scale scores for somatic, psychological
and urogenital symptoms were calculated separately.
We used non-parametric receiver operating characteris-
tic (ROC) curves command in STATA (version10) to
calculate the sensitivity, specificity, positive predictive
values and likelihood ratios for different MRS scores to
identify the women who are likely be referred to a
gynaecologist for severe menopausal symptoms. By this
method, we also calculated area under curve (AUC) and
its 95% confidence intervals (95% CIs) for total MRS
score. We also carried out a multivariate analysis on
SPSS package (version 14) to find out the predictors for
referral to a gynaecologist. Referral to a gynaecologist at
least once was considered as a dependant variable. Age,
self-reported general health, presence of any chronic
disease, regularity of menstrual cycles, history of dysme-
norrhoea, history of abortions and scores of MRS sub
scales i.e. scores for somatic, psychological and urogen-
ital symptoms were treated as dependant variables.
Results
Response rates and demographic characteristics
During the survey period, 1179 women attended the
health screening camps. When the eligibility criteria were
applied 18 women were either pregnant or were lactating,
one woman had received treatment for a genital malig-
nancy and one woman had reached premature meno-
pause (i.e. before 40 years of age). Ninety four women
had undergone treatment for chronic psychiatric illness
of whom, 62 were chronic alcoholics. Thus 1065 eligible
women were invited to participate in the survey interview
but 336 women declined to participate. The main reasons
for refusal were the need to return back home quickly or
non-comprehension about the nature of interview to be
carried out. We interviewed 729 women giving a
response rate of 68.5% (729/1065). Demographic charac-
teristics of the women are shown in table 1. Mean age of
the women interviewed was 49.9 years (SD = 5.6). Med-
ian age was 49 years (lower quartile i.e. Q1 & upper quar-
tile i.e. Q3 were 46 and 53 years respectively). Mean age
of the women according to menopausal status (classified
according to STRAW) were as follows: premenopausal
45.1 years (SD = 2.78), perimenopausal 49.14 years (SD =
2.01), postmenopausal 55.67 years (SD = 5.6). Majority
(88.6%) of the women were currently married. Of these,
574 (78.7%) women were living with their husbands. The
women we interviewed were mostly illiterates (468,
64.9%) and mainly housewives (528, 72.4%).
Health status and frequency of menopausal symptoms
One hundred and eighty six women (25.5%) rated their
general health as poor, while 127 (17.4%) women had
one or more chronic disease. The main chronic diseases
t h ew o m e nh a dw e r eC h r o n i cO b s t r u c t i v eP u l m o n a r y
Disease (58), hypertension (34), diabetes (26), others (9)
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visited a gynaecologist for menopausal symptoms and
21 (2.9%) of them had undergone hormone replacement
therapy. Frequency and severity of the menopausal
symptoms are shown in table 2. Most frequent somatic
symptoms were sleeping problems, (574, 78.7%) hot
flushes (508, 69.7%) and joint and muscular discomfort
(500, 68.6%). Among psychological symptoms, physical
and mental exhaustion were reported by 536 (73.5%)
women. Among the urogenital symptoms, dryness of
vagina was reported by 449 (61.6%) women and 385
(52.8%) women reported bladder problems. Among all
the menopausal symptoms, hot flushes were perceived
as severe (157, 21.5%) and very severe (75, 10.3%).
Other symptoms that were perceived as severe were:
anxiety (114, 15.6%), depressive mood (109, 14.9%),
irritability (105, 14.4%), dryness of vagina (102, 13.9%).
The differences between three groups of menopausal
status for all the symptoms were statistically significant
(Table 3). MRS score including the sub scale scores and
severity of symptoms were significantly higher among
postmenopausal women than the perimenopausal and
premenopausal women (table 4).
Predictors of severe menopausal symptoms
Table 5 shows the predictors for referral to a gynaecolo-
gist for evaluation of severe menopausal symptoms by
univariate and multivariate analyses. On univariate ana-
lysis, self-reported poor general health, presence of
chronic disease, irregular menstrual cycles, dysmenor-
rhoea and occurrence of all three groups of menopausal
symptoms were associated with referral to a gynaecolo-
gist. On multivariate analysis, women reporting poor
general health (OR 5.29, 95% CI 2.59 10.78) were likely
to be referred. Among menopausal symptoms women
reporting somatic (OR 0.72, 95% CI 0.63 0.82) and psy-
chological (OR 0.86, 95% CI 0.74 0.99) symptoms were
less likely to be referred. Women reporting urogenital
(OR 1.29, 95% 1.11 1.53) symptoms were more likely to
be referred to a gynaecologist for further evaluation.
Validity of MRS as a screening tool
The sensitivity, specificity, positive predictive values and
likelihood ratios for different MRS scores to identify the
women who are likely to be referred to a gynaecologist
for severe menopausal symptoms are shown in table 6
and in Figure 1 by non-parametric receiver operating
characteristic (ROC) curves. The area under the curve
(AUC) was calculated using the non-parametric method
o fD eL o n g .W ec h o s ea no p t i m u mc u t - o f fp o i n ta ta
total MRS score where the ratio (sensitivity + specifi-
city)/2 was highest. At this point the lowest total mis-
classification error rate was expected [23]. This criterion
was chosen to allow for comparison with previous
studies available in the literature [24]. The optimal cut-
off MRS score for referral to gynaecologist was 16. The
area under curve was 0.79 (95% CI 0.74 0.84).
Table 1 Socio-demographic profile of the participants
Characteristic Number Percentage
Age
40-44 130 17.8
45-49 269 36.9
50-54 195 26.7
55-59 70 9.6
60-64 65 8.9
Marital status
Currently married 646 88.6
Divorced 28 3.8
Widowed 54 7.4
Education level
Illiterate 468 64.9
Primary level 121 16.6
Secondary level 93 12.8
Tertiary level 47 6.4
Living situation
With partner 574 78.7
With children/others 150 20.6
Alone 4 0.5
Occupation
Housewife 528 72.4
General worker 154 21.1
Semi professional 42 5.8
Professional 5 0.7
Table 2 Frequency and severity of menopausal
symptoms
Menopausal symptoms Number (%) Severe Very severe
Somatic
Sleeping problems 574 (78.7) 93 1
Hot flushes, sweating 508 (69.7) 157 75
Joint and muscular discomfort 500 (68.6) 86 0
Heart discomfort 360 (49.4) 0 0
Psychological
Physical and mental exhaustion 536 (73.5) 68 4
Depressive mood 402 (55.2) 109 12
Irritability 339 (46.5) 105 10
Anxiety 334 (45.8) 114 7
Urogenital
Dryness of vagina 449 (61.6) 102 4
Bladder problems 385 (52.8) 38 2
Sexual problems 343 (47.1) 56 6
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Our health facility-based survey among midlife women
with an interviewer administered MRS could identify
the frequency and severity of menopausal symptoms
among rural and largely illiterate women. MRS fared
well as a screening instrument and a total MRS score of
16 and above could be considered as an optimal cut-off
point for referral to a gynecol o g i s t .H o w e v e r ,s u bs c a l e
score for urogenital symptoms was a better predictor for
referral to a gynaecologist. The optimistic results of our
survey on a relatively large sample of women should be
interpreted carefully in the light of some limitations we
had. The sample of women we surveyed, were from
catchment area of two health facilities where the
women’s health camps were held. This makes our sam-
ple non-representative of Nepalese women, thus limiting
the external validity. Further, all women may not have
correctly recalled the symptoms listed in the MRS and
about referral to a gynaecologist for evaluation of severe
menopausal symptoms. There may also have been an
element of subjectivity while assessing the severity of
symptoms. Response rates were not high mainly due to
crowding caused during free of cost health camps and
lack of comprehension by lesser educated women. So
there may have been some selection bias.
The prevalence and proportion of menopausal symp-
toms may vary according to racial and ethnic groups.
Population-based surveys among Caucasian populations
have reported a higher prevalence (40 -70%) [25-27]
while those from Asian countries have reported a lower
prevalence (10-50%) [6]. Three studies from Turkey
have reported varying prevalence (35-90%) [28-30]. In
our survey, though all symptoms were reported, the pro-
portion of women reporting symptoms listed in MRS
varied. Sleep disorders, physical and mental exhaustion
were most common symptoms. Prevalence of hot
flushes and sweating in our survey was nearly same as
prevalence reported from western countries. Though
hot flushes was not a common symptom was perceived
as ‘severe’ and ‘very severe’. Hot flushes, sweating, vagi-
nal dryness and sleep disturbances are considered the
main climacteric complaints in western countries
[31-33]. Similarly, hot flushes and sweating were the
most common complaints among Turkish women [34].
Table 3 Distribution of menopausal symptoms according to menopausal status
Menopausal symptoms All (%) N = 729 Premenopause
N = 267
Perimenopause
N = 215
Post menopause
N = 247
Somatic
Sleeping problems 574 (78.7) 160 (59.9) 185 (86.1) 229 (92.7)
Hot flushes, sweating 508 (69.7) 61 (22.8) 204 (94.9) 243 (98.4)
Joint and muscular discomfort 500 (68.6) 130 (48.7) 167 (77.7) 203 (82.2)
Heart discomfort 360 (49.4) 81 (30.3) 111 (51.6) 168 (68.0)
Psychological
Physical & mental exhaustion 536 (73.5) 153 (57.3) 171 (79.5) 212 (85.8)
Depressive mood 402 (55.2) 112 (41.9) 138 (64.2) 152 (61.5)
Irritability 339 (46.5) 60 (22.5) 134 (62.3) 145 (58.7)
Anxiety 334 (45.8) 90 (33.7) 104 (48.4) 140 (56.7)
Urogenital
Dryness of vagina 449 (61.6) 61 (22.8) 173 (80.5) 215 (87.1)
Bladder problems 385 (52.8) 92 (34.5) 128 (59.5) 165 (66.8)
Sexual problems 343 (47.1) 111 (41.6) 166 (77.2) 199 (80.6)
* All comparisons were statistically significant (p < 0.01) by chi square test
Table 4 Comparison of MRS scores and severe menopausal symptoms according to the menopausal status
Variable Premenopause
N = 267
Perimenopause
N = 215
Postmenopause
N = 247
p-value
Total MRS score (Mean & SD) 5.3 (3.79) 12.28 (3.36) 16.24 (4.81) < 0.001*
Somatic symptoms (Mean & SD) 2.17 (2.06) 5.27 (1.96) 7.17 (2.34) < 0.001*
Psychological symptoms (Mean & SD) 1.82 (1.31) 3.61 (1.60) 4.36 (2.12) < 0.001*
Urogenital symptoms (Mean & SD) 1.30 (1.51) 3.39 (1.70) 4.72 (2.11) < 0.001
Severe symptoms (Number and percentage) 8 (2.9) 41 (19.1) 154 (62.3) < 0.001 a
* ANOVA test a Chi square test
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most common symptoms among both perimenopausal
and postmenopausal women. These symptoms can be
explained by the physiological fluctuations in oestrogen
levels. Similar results were reported from studies carried
out among Caucasian, Australian and South-east Asian
women [35-38,38,39]. The probability for occurrence of
other symptoms is higher if the woman had experienced
vasomotor symptoms [40]. Several studies from Asian
countries have also reported a lower prevalence of clas-
sical menopausal symptoms [35-38,41-44]. Such variabil-
ity of menopausal symptoms is not well known. This
may be due to woman’s attitude and awareness, or
socio-cultural and economic factors.
Symptoms reported during mid-life may also be influ-
enced by various factors [45]. These may be due to
increased levels of physical and mental stress requiring
support and coping mechanisms. Socio-cultural milieu
and economic factors may also affect these support and
coping mechanisms. Reports suggest that menopausal
symptoms may also be confounded by symptoms attri-
butable to genetic factors and aging per se [32]. There-
fore, the symptoms reported may not be attributable to
climacteric itself. This argument may be supported by
our results, where the commonest symptoms reported
by premenopausal women were physical and mental
exhaustion and sleep disorders. All premenopausal
women had reported symptoms given in the MRS ques-
tionnaire. Our findings support the view that symptoms
experienced by these women may have originated from
physical and psychological problems the women had but
not as a menopausal symptom alone [1,46]. The propor-
tion of women reporting their general health as poor
and visiting a gynaecologist for their menopausal symp-
toms was only a tenth. However the same proportions
Table 5 Multivariate analysis of predictors of referral to a
gynaecologist for evaluation of severe menopausal
symptoms
Variable Univariate
OR (95% CI)
p-value Adjusted
OR (95% CI)
p-value
Age 0.89
(0.86, 0.93)
< 0.001 1.01
(0.94, 1.07)
0.859
General health
Good 1 1
Poor 10.16
(5.93, 17.43)
< 0.001 5.29
(2.59, 10.78)
< 0.001
Chronic disease
No 1 1
Yes 1.86
(1.07, 3.23)
0.028 1.54
(0.78, 3.04)
0.21
Regular menstrual cycles
Yes 1 1
No 6.63
(2.83, 15.48)
< 0.001 0.53
(0.19, 1.46)
0.217
Dysmenorrhea
No 11
Yes 2.04
(1.05, 3.96)
0.035 0.97
(0.44, 2.15)
0.939
Abortions
None 1 1
One or more 1.25
(0.74, 2.10)
0.402 0.90
(0.49, 1.64)
0.736
Menopausal symptoms
Somatic
symptoms
0.64
(0.57, 0.71)
< 0.001 0.72
(0.63, 0.82)
< 0.001
Psychological
symptoms
0.67
(0.60, 0.76)
< 0.001 0.86
(0.74, 0.99)
0.046
Urogenital
symptoms
0.81
(0.73, 0.89)
< 0.001 1.29
(1.11, 1.53)
0.001
Table 6 Sensitivity, Specificity, positive predictive values
and likelihood ratios for predicting the women who
should likely be referred to a gynaecologist for
evaluation of severe menopausal symptoms
Cut-off
point
Sensitivity Specificity Correctly
classified
LR+ LR-
( > = 1 ) 100.00% 0.00% 10.29% 1
( > = 2 ) 100.00% 1.38% 11.52% 1.014 0
( > = 3 ) 100.00% 8.26% 17.70% 1.09 0
( > = 4 ) 100.00% 14.98% 23.73% 1.1763 0
( > = 5 ) 100.00% 24.62% 32.37% 1.3266 0
( > = 6 ) 98.67% 30.12% 37.17% 1.412 0.0443
( > = 7 ) 97.33% 34.71% 41.15% 1.4908 0.0768
( > = 8 ) 93.33% 36.39% 42.25% 1.4673 0.1832
( > = 9 ) 88.00% 40.83% 45.68% 1.4871 0.2939
( > = 10 ) 88.00% 44.34% 48.83% 1.5811 0.2706
( > = 11 ) 86.67% 48.32% 52.26% 1.6769 0.2759
( > = 12 ) 85.33% 53.98% 57.20% 1.8541 0.2717
( > = 13 ) 81.33% 61.31% 63.37% 2.1025 0.3044
( > = 14 ) 78.67% 67.74% 68.86% 2.4383 0.3149
( > = 15 ) 72.00% 72.32% 72.29% 2.6015 0.3871
( > = 16 ) 69.33% 76.91% 76.13% 3.0029 0.3987
( > = 17 ) 62.67% 82.42% 80.38% 3.5638 0.453
( > = 18 ) 49.33% 88.07% 84.09% 4.1364 0.5753
( > = 19 ) 41.33% 90.37% 85.32% 4.2908 0.6492
( > = 20 ) 26.67% 93.58% 86.69% 4.1524 0.7837
( > = 21 ) 18.67% 95.57% 87.65% 4.2097 0.8511
( > = 22 ) 16.00% 97.09% 88.75% 5.5074 0.8651
( > = 23 ) 10.67% 98.17% 89.16% 5.8133 0.91
( > = 24 ) 6.67% 98.47% 89.03% 4.36 0.9478
( > = 25 ) 5.33% 99.08% 89.44% 5.8134 0.9554
( > = 26 ) 0.00% 99.69% 89.44% 0 1.0031
( > = 28 ) 0.00% 99.85% 89.57% 0 1.0015
( > 28 ) 0.00% 100.00% 89.71% 1
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[30,47].
On multivariate analysis, women who reported their
general health as poor were likely to be referred to a
gynaecologist for evaluation. Similar results have been
reported by other studies [17,18,48]. We found that
women reporting urogenital symptoms were more likely
to be referred to a gynaecologist for further evaluation.
Women with somatic and psychological symptoms were
less likely to be referred to a gynaecologist for evalua-
tion of symptoms. Women with psychological and
somatic symptoms may not have attributed their symp-
toms to menopause. As we discussed above these
somatic and psychological symptoms may be as result of
physical and psychological stress, these rural women
experience during midlife. Therefore, the women may
have over-rated their symptoms as menopausal symp-
toms when MRS was administered to them. On the con-
trary to the report from Turkey, presence of a chronic
disease was not a predictor for referral to a gynaecolo-
gist. We expect that self-reported health status and pre-
sence of chronic disease may have confounded the
predictors of referral for severe menopausal symptoms.
U s eo fM R Si n s t r u m e n ta sas c r e e n i n gt o o lm a yb e
affected by these confounding factors as discussed
above. Urogenital symptoms seem to be more specific
than the psychological and somatic symptoms. This
result should be verified by future studies minimising
the misreporting of menopausal symptoms when MRS
is administered. The optimal cut-off for MRS score we
obtained for referral to a gynaecologist was ≥16 and the
sensitivity and specificity values at this cut-off are com-
parable to those reported from MRS validation study
[49] and indicate a better reliability than a similar study
from reported from Turkey [17]. The method we
adopted to determine the cut-off score was in accor-
dance to literature available about validation of screen-
ing instruments in rural areas. To our knowledge, there
are very few studies which have tested the validity of
MRS as screening tool. The potential utility of MRS as a
screening instrument to be administered by paramedical
workers should be further established. However, such
potential utility appears to be limited by misclassifica-
tion of somatic and psychological symptoms arising
from other causes as ‘menopausal’. Utility of MRS as a
screening instrument should be carefully considered to
avoid too many false positives being referred for evalua-
tion of severe menopausal symptoms. Such excess refer-
rals may cause an additional burden on medical
personnel in resource-limited rural settings like Nepal.
Figure 1 Receiver operator characteristic curve to determine the cut-off point to MRS score for referral to a gynaecologist.
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The symptoms reported by the women according to
MRS were concordant to the existing literature about
the utility of MRS to assess menopausal symptoms.
Though symptoms reported were similar to those
reported by women from other Asian countries, there
may have been over-reporting of some psychological
and somatic symptoms. Urogenital symptoms appear to
be more specific for referral to a gynaecologist. Further
studies are required to confirm or refute the utility of
MRS as a screening instrument.
Additional material
Additional file 1: Questionnaire used for the survey Socio-
demographic information, Reproductive history, STRAW
classification and chronic disease information.
Additional file 2: English Version of Menopause Rating Scale. Eleven
questions about menopausal symptoms and their severity in a five point
Likert scale.
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